Complete Filing Data
Bioceres Crop Solutions Corp. reported Cash And Cash Equivalents If Different From Statement Of Financial Position of $32.70 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Bioceres Crop Solutions Corp. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | -$1.1M | $4.0M | $1.2M | $1.1M | $997.4K | $2.5M | $1.0M | -$2.1M | -$707.0K |
| Selling General And Administrative Expense | $123.1M | $123.7M | $113.0M | $77.5M | $47.6M | $38.3M | $39.2M | $35.3M | $8.8M |
| Revenue From Contracts With Customers | $333.3M | $464.8M | $419.4M | $328.5M | $206.7M | $172.4M | $160.3M | $133.5M | $41.0M |
| Research And Development Expense | $14.9M | $17.2M | $15.3M | $6.9M | $5.6M | $4.2M | $3.7M | $4.0M | $853.9K |
| Profit Loss From Operating Activities | -$2.2M | $45.9M | $54.2M | $39.9M | $38.4M | $39.1M | $32.1M | $15.7M | $207.0K |
| Profit Loss Before Tax | -$57.6M | $11.1M | $19.1M | $14.1M | $10.5M | $6.4M | -$9.4M | -$25.2M | -$8.0M |
| Profit Loss | -$58.8M | $7.3M | $20.2M | -$3.9M | -$3.8M | $4.2M | -$16.4M | -$14.3M | -$6.2M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net Of Tax | -$714.3K | -$787.4K | $631.5K | $40.5M | $12.7M | -$13.6M | $5.3M | -$43.7M | -$4.6M |
| Income Tax Expense Continuing Operations | $1.3M | $3.8M | -$1.1M | $18.0M | $14.4M | $2.2M | $7.0M | -$10.9M | -$1.9M |
| Cost Of Sales | $203.4M | $278.2M | $235.5M | $208.4M | $118.6M | $93.6M | $87.0M | $77.1M | $30.6M |
| Comprehensive Income | -$59.6M | $6.5M | $19.3M | $31.3M | $6.2M | -$5.4M | -$12.5M | -$46.1M | -$10.8M |
| Other Comprehensive Income | -$714.3K | -$787.4K | -$835.8K | $35.2M | $10.1M | -$9.7M | $3.9M | -$31.8M | -$4.6M |
| Profit Loss Attributable To Owners Of Parent | -$55.4M | $4.3M | $18.8M | -$7.2M | -$6.9M | $3.4M | -$18.4M | -$11.0M | -$5.9M |
| Profit Loss Attributable To Noncontrolling Interests | -$3.4M | $3.0M | $1.4M | $3.3M | $3.0M | $877.5K | $2.0M | -$3.3M | -$316.0K |
| Comprehensive Income Attributable To Owners Of Parent | -$56.0M | $3.8M | $17.9M | $22.1M | $1.6M | -$5.2M | -$14.3M | -$33.9M | -$9.1M |
| Comprehensive Income Attributable To Noncontrolling Interests | -$3.6M | $2.7M | $1.4M | $9.1M | $4.7M | -$222.9K | $1.9M | -$12.2M | -$1.7M |
| Adjustments For Income Tax Expense | $1.3M | $3.8M | -$1.1M | $18.0M | $14.4M | $2.2M | $7.0M | -$10.9M | -$1.9M |
| Adjustments For Decrease Increase In Income And Minimum Presumed Income Taxes | -$7.0M | $4.8M | -$16.2M | $6.5M | $5.8M | $1.2M | $2.8M | -$126.8K | $3.6M |
| Adjustments For Decrease Increase In Deferred Revenue And Advances From Customers | -$128.7K | -$21.1M | $13.3M | -$373.6K | $2.4M | $844.0K | $66.2K | -$162.5K | $634.4K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents If Different From Statement Of Financial Position | $32.7M | $44.5M | $48.1M | $33.5M | $36.0M | $42.5M | $3.5M | $2.2M | $1.7M | $982.9K | $20.5K |
| Gains Losses On Fair Value Adjustment Biological Assets | $1.8M | -$45.7K | $610.6K | $6.4M | $2.8M | $716.7K | $279.9K | ||||
| Property Plant And Equipment | $74.6M | $74.6M | $67.9M | $49.9M | $48.0M | $41.5M | $43.8M | $40.2M | $46.2M | $46.4M | |
| Intangible Assets Other Than Goodwill | $181.2M | $176.9M | $173.8M | $76.7M | $67.3M | $35.3M | $39.6M | $26.7M | $42.1M | $42.4M | |
| Biological Assets | $2.4M | $294.1K | $146.8K | $57.3K | $2.3M | $965.7K | $270.6K | $0.00 | |||
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $5.6M | $9.8M | $11.4M | $3.5M | $2.8M | $1.6M | $2.0M | $2.8M | $608.1K | ||
| Purchase Of Intangible Assets Classified As Investing Activities | $350.8K | $1.1M | $449.7K | $389.0K | $7.2M | $1.6M | $722.8K | $614.5K | $420.3K | ||
| Other Inflows Outflows Of Cash Classified As Financing Activities | -$3.2M | -$2.7M | -$4.8M | -$180.5K | -$1.4M | $2.3M | -$854.7K | -$1.8M | -$883.1K | ||
| Cash Flows From Used In Operating Activities | $49.9M | $41.7M | $2.6M | -$17.5M | -$6.2M | $9.3M | $29.7M | $18.4M | -$1.2M | ||
| Cash Flows From Used In Investing Activities | -$6.1M | -$28.7M | -$25.7M | $2.9M | -$8.3M | -$7.8M | -$3.3M | -$8.2M | -$41.9M | ||
| Cash Flows From Used In Financing Activities | -$50.7M | -$10.1M | $33.0M | $14.8M | $7.4M | $33.5M | -$26.9M | -$10.5M | $44.0M | ||
| Adjustments For Losses Gains On Disposal Of Noncurrent Assets | -$7.8M | -$125.5K | -$74.6K | -$1.9M | $733.0K | $297.3K | $91.8K | $4.8K | -$13.8K | ||
| Adjustments For Increase Decrease In Trade And Other Payables | -$32.0M | $14.2M | -$4.5M | $53.5M | -$5.8M | $8.3M | -$33.7M | -$35.3M | -$3.2M | ||
| Adjustments For Decrease Increase In Trade Account Receivable | $25.5M | -$46.7M | -$56.9M | -$25.0M | $2.0M | -$21.7M | $41.5M | $17.3M | -$11.3M | ||
| Adjustments For Decrease Increase In Other Operating Receivables | -$916.4K | -$5.0M | -$11.5M | -$7.3M | -$8.3M | -$4.9M | $5.8M | $513.2K | -$3.5M | ||
| Trade And Other Current Payables | $96.4M | $168.7M | $150.8M | $125.8M | $72.1M | $57.3M | $40.6M | $27.7M | $22.8M | ||
| Other Noncurrent Receivables | $23.7M | $18.0M | $2.5M | $2.3M | $2.5M | $1.7M | $1.6M | $5.0M | $2.2M | ||
| Other Noncurrent Financial Assets | $58.00 | $634.6K | $444.9K | $619.8K | $1.1M | $322.7K | $376.4K | $243.4K | $767.0K | ||
| Other Current Receivables | $15.9M | $18.3M | $28.8M | $19.3M | $11.2M | $4.8M | $2.0M | $4.2M | $7.1M | ||
| Other Current Financial Assets | $2.0M | $11.7M | $12.1M | $5.4M | $11.2M | $13.4M | $4.7M | $4.6M | $4.3M | ||
| Noncurrent Liabilities | $130.4M | $171.9M | $188.9M | $137.3M | $136.3M | $106.2M | $63.9M | $44.8M | $93.2M | ||
| Noncurrent Assets | $455.3M | $443.9M | $420.9M | $220.5M | $183.1M | $132.9M | $144.3M | $111.3M | $152.1M | ||
| Liabilities | $468.4M | $501.2M | $487.6M | $359.9M | $304.3M | $236.8M | $180.4M | $163.5M | $162.6M | ||
| Goodwill | $112.2M | $112.2M | $112.2M | $36.1M | $28.8M | $25.5M | $29.8M | $14.4M | $25.1M | ||
| Equity Attributable To Owners Of Parent | $265.4M | $315.0M | $298.6M | $127.4M | $67.7M | $46.2M | $47.3M | $13.7M | $35.8M | ||
| Equity And Liabilities | $763.6M | $852.5M | $818.1M | $518.2M | $394.6M | $297.6M | $242.5M | $196.6M | $239.9M | ||
| Deferred Tax Liabilities | $30.1M | $35.0M | $35.8M | $29.0M | $25.7M | $16.9M | $21.1M | $13.6M | $25.6M | ||
| Deferred Tax Assets | $4.9M | $9.7M | $7.3M | $4.0M | $3.3M | $2.7M | $3.7M | $5.6M | $3.4M | ||
| Current Tax Assets Noncurrent | $18.0K | $10.9K | $16.3K | $44.4K | $12.6K | $6.0K | $1.2K | $126.7K | $315.6K | ||
| Current Tax Assets | $1.9M | $655.7K | $9.4M | $1.6M | $990.9K | $112.2K | $1.3M | $2.1M | $1.7M | ||
| Current Liabilities | $338.0M | $329.3M | $298.7M | $222.7M | $168.0M | $130.6M | $116.5M | $118.7M | $69.4M | ||
| Current Assets | $308.3M | $408.7M | $397.1M | $297.7M | $211.5M | $164.7M | $98.2M | $85.3M | $87.8M | ||
| Cash And Cash Equivalents | $32.7M | $44.5M | $48.1M | $33.5M | $36.0M | $42.5M | $3.5M | $2.2M | $1.7M | ||
| Assets | $763.6M | $852.5M | $818.1M | $518.2M | $394.6M | $297.6M | $242.5M | $196.6M | $239.9M | ||
| Trade And Other Current Receivables | $207.3M | $158.0M | $111.8M | $88.8M | $73.5M | $59.2M | $52.9M | $41.7M | |||
| Inflation Effects On Cash And Cash Equivalents | $2.6K | -$31.9K | -$101.8K | -$9.6M | -$5.6M | -$552.5K | $1.7M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|
| Proceeds From Borrowings Classified As Financing Activities | $266.4M | $135.8M | $79.8M | $140.4M | $143.5M | $135.3M | $88.7M | $27.7M | $10.5M |
| Payments For Development Project Expenditure | $8.6M | $11.9M | $10.8M | $5.1M | $3.9M | $1.3M | $682.5K | $2.3M | $175.5K |
| Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes | -$6.9M | $2.9M | $9.8M | $211.2K | -$7.2M | $35.0M | -$512.2K | -$290.6K | $875.6K |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -$4.9M | -$6.6M | $4.9M | $6.8M | $6.3M | $4.6M | $66.9K | $826.2K | $86.8K |
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | $390.4K | $336.7K | $137.4K | $2.0M | $309.8K | $51.2K | $318.0K | $109.7K | $13.8K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Diluted Earnings Loss Per Share | $-0.88 | $0.07 | $0.30 | $-0.17 | $-0.18 | $0.09 | $-0.60 | $-0.39 |
| Basic Earnings Loss Per Share | $-0.88 | $0.07 | $0.30 | $-0.17 | $-0.18 | $0.09 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Other Operating Income Expense | $6.8M | -$1.5M | $1.1M | -$3.3M | -$279.4K | -$307.5K | $365.9K | $613.4K | $24.8K | |
| Gains Losses On Exchange Differences On Translation Net Of Tax | -$714.3K | -$787.1K | $678.4K | $32.6M | $10.1M | -$10.1M | $5.2M | -$29.8M | -$4.3M | |
| Repayments Of Borrowings Classified As Financing Activities | $288.5M | $112.6M | $16.7M | $110.6M | $113.1M | $101.3M | $111.1M | $37.6M | $6.4M | |
| Adjustments For Provisions | $335.8K | $367.1K | $221.0K | $292.7K | $158.8K | $200.5K | -$246.8K | $46.1K | $293.0K | |
| Adjustments For Obsolescence | $1.5M | $586.5K | $1.1M | $849.6K | $579.8K | $977.8K | $564.9K | $661.8K | $982.4K | |
| Adjustments For Finance Costs | $55.3M | $34.8M | $35.1M | $25.8M | $27.9M | $32.7M | $41.5M | $41.0M | $8.2M | |
| Adjustments For Depreciation Expense | $6.0M | $5.8M | $4.8M | $3.8M | $3.0M | $2.0M | $2.5M | $2.2M | $584.3K | |
| Adjustments For Decrease Increase In Employee Benefits And Social Security | -$1.2M | -$2.3M | $1.3M | $3.0M | -$693.1K | -$477.9K | $931.4K | -$543.9K | $3.8M | |
| Adjustments For Amortisation Expense | $11.2M | $12.1M | $11.0M | $4.2M | $2.4M | $2.1M | $2.4M | $2.1M | $424.2K | |
| Other Finance Income Cost | -$26.5M | -$7.9M | -$11.3M | -$7.9M | -$6.6M | -$11.8M | -$18.0M | -$23.8M | ||
| Finance Income Cost | -$25.8M | -$27.9M | -$32.7M | -$41.5M | -$41.0M | -$8.2M | ||||
| Shortterm Borrowings | $119.7M | $136.7M | $107.6M | $71.3M | $76.8M | $63.7M | $66.5M | $65.3M | $34.0M | |
| Noncontrolling Interests | $29.8M | $36.3M | $31.9M | $30.9M | $22.5M | $14.6M | $14.8M | $19.4M | $41.4M | |
| Longterm Borrowings | $38.2M | $42.1M | $60.7M | $74.2M | $48.0M | $41.2M | $37.1M | $25.7M | $41.0M | |
| Inventories | $87.6M | $125.9M | $140.4M | $126.0M | $61.0M | $29.3M | $27.3M | $19.4M | $31.3M | |
| Current Provisions For Employee Benefits | $6.2M | $7.3M | $9.6M | $7.6M | $4.7M | $4.5M | $5.4M | $4.4M | $5.0M | |
| Adjustments For Decrease Increase In Inflation Effects On Working Capital Adjustments | $139.9K | $321.1K | $376.6K | -$35.8M | -$14.7M | -$16.7M | -$18.4M |
Most recent annual filing with the SEC: November 10, 2025
Data sourced from SEC EDGAR public filings as of August 9, 2026.